By Gina Lee
Investing.com – The dollar rose on Wednesday morning in Asia, but its five-week high was capped by a report that cast doubt on a potential vaccine against the COVID-19 virus.
Medical news website STAT released a report Tuesday, doubting Moderna ‘s (NASDAQ 🙂 announcement on Monday that its potential vaccine generated an immune response in all 45 patients in its Phase 1 trial.
The report said the U.S. drug manufacturer had provided insufficient data to determine the efficacy of the vaccine.
Investors turned to dollars at the safe haven after the report dashed hopes of a possible cure for the virus.
What traces the greenback to a basket of other currencies rose 0.09% to 99.460 at. 12:03 PM ET (5:03 AM GMT). The dollar has been firmly in this well-worn range since the beginning of April.
The pair rose 0.12% to 107.81.
The pair rose 0.10% to 7.1051. China’s central bank announced earlier in the day that it would not change its loan rates in line with investor expectations. The 1-year mortgage rate remains at 3.85% and the 5-year loan rate is constant at 4.65%.
Meanwhile, U.S.-Chinese tensions continue to simmer in the background.
The pair rose 0.24% to 0.6552 and it rose 0.62% to 0.6111.
The pair rose 0.08% to 1.2660. Tuesday’s Franco-German proposal for a joint fund of $ 500 billion EUR ($ 546.506 billion) to tackle COVID-19, increasing Euro and investor sentiment.
Fusion Media or anyone involved with Fusion Media assumes no liability for any loss or damage arising from the reliance on the information, including data, offers, charts and the purchase / sale of signals on this site. Be fully informed about the risks and costs associated with trading in the financial markets, it is one of the most risky types of investment.